Eden Biodesign appoints Roger Lias as president Eden Biodesign, USA
Eden Biodesign Ltd announced the appointment of Dr Roger Lias as President Eden Biodesign, USA. Roger has extensive experience in the biotechnology industry with a specific emphasis on biomanufacturing services. Roger's responsibilities will include identifying and establishing strategic business partnerships and expanding Eden Biodesign's offer to the large US biopharmaceutical sector.
Roger Lias joins Eden Biodesign from Cytovance Biologics, where he has held the position of Vice President, Sales and Business Development since 2004, assuming responsibility for the entire commercial function. During this period he built the company's infrastructure, marketing programs and the initial customer base. At KBI BioPharma, a start-up contract biomanufacturing company, Roger played an active role in securing funding and building revenues. His responsibilities also included identifying and establishing strategic business partnerships and establishing new business relationships. Prior to that he was Vice President, Business Development at Diosynth where he had global responsibility and previously headed North American sales and marketing for Lonza Biologics. In both cases Roger was instrumental in generating substantial revenue growth.
Other news from the department people
